| 1 | CCL19, CCR7, MAPK7, S1PR1
|
| CCR7/CCL19 controls expression of EDG-1 in T cells.
|
| Shannon LA, McBurney TM, Wells MA, Roth ME, Calloway PA, Bill CA, Islam S, Vines CM.
|
| J Biol Chem 287(15):11656-64. doi: 10.1074/jbc.M111.310045. Epub 2012 Feb 13.
2012
|
| 2 | CCL19, CCL21
|
| Combinatorial guidance by CCR7 ligands for T lymphocytes migration in co-existing chemokine fields.
|
| Nandagopal S, Wu D, Lin F.
|
| PLoS One 6(3):e18183.
2011
|
| 3 | CCL19, CCRL2
|
| CCL19 is a specific ligand of the constitutively recycling atypical human chemokine receptor CRAM-B.
|
| Leick M, Catusse J, Follo M, Nibbs RJ, Hartmann TN, Veelken H, Burger M.
|
| Immunology 129(4):536-46. Epub 2009 Dec 2.
2010
|
| 4 | CCL19, CCL21
|
| Analysis of migratory and prosurvival pathways induced by the homeostatic chemokines CCL19 and CCL21 in B-cell chronic lymphocytic leukemia.
|
| Cuesta-Mateos C, López-Giral S, Alfonso-Pérez M, de Soria VG, Loscertales J, Guasch-Vidal S, Beltrán AE, Zapata JM, Muñoz-Calleja C.
|
| Exp Hematol 38(9):756-64, 764.e1-4. Epub 2010 May 19.
2010
|
| 5 | CCL19, FHL2
|
| Four-and-a-half LIM domain protein 2 is a novel regulator of sphingosine 1-phosphate receptor 1 in CCL19-induced dendritic cell migration.
|
| König K, Diehl L, Rommerscheidt-Fuss U, Golletz C, Quast T, Kahl P, Kolanus W, Knolle P, Buettner R, Heukamp LC.
|
| J Immunol 185(3):1466-75. Epub 2010 Jun 30.
2010
|
| 6 | CCL19, CCR7
|
| Macrophages participate in lymphangiogenesis in idiopathic diffuse alveolar damage through CCL19-CCR7 signal.
|
| Yamashita M, Iwama N, Date F, Shibata N, Miki H, Yamauchi K, Sawai T, Sato S, Takahashi T, Ono M.
|
| Hum Pathol 40(11):1553-63. Epub 2009 Jun 21.
2009
|
| 7 | CCL22, CCL20, CCL19
|
| Chemokine redundancy in BOS pathogenesis. A possible role also for the CC chemokines: MIP3-beta, MIP3-alpha, MDC and their specific receptors.
|
| Meloni F, Solari N, Miserere S, Morosini M, Cascina A, Klersy C, Arbustini E, Pellegrini C, Vigan˜ M, Fietta AM.
|
| Transpl Immunol 18(3):275-80. Epub 2007 Sep 5. 2008
|
| 8 | CCl19, CCL21
|
| The N-terminal domain of CCL21 reconstitutes high affinity binding, G protein activation, and chemotactic activity, to the C-terminal domain of CCL19.
|
| Ott TR, Lio FM, Olshefski D, Liu XJ, Ling N, Struthers RS.
|
| Biochem Biophys Res Commun 348(3):1089-93. Epub 2006 Aug 4. 2006
|
| 9 | CCL19, CCL21, CCR7
|
| Expression of CCR7 and its ligands CCL19/CCL21 in muscles of polymyositis.
|
| Tateyama M, Fujihara K, Misu T, Feng J, Onodera Y, Itoyama Y.
|
| J Neurol Sci 249(2):158-65. Epub 2006 Aug 2. 2006
|
| 10 | CCL19
|
| CC chemokine ligand 19 secreted by mature dendritic cells increases naive T cell scanning behavior and their response to rare cognate antigen.
|
| Kaiser A, Donnadieu E, Abastado JP, Trautmann A, Nardin A.
|
| J Immunol 175(4):2349-56. 2005
|
| 11 | ISG20, MAP4K3, CCL19
|
| Identification of genes specifically expressed in human activated and mature dendritic cells through serial analysis of gene expression.
|
| Hashimoto SI, Suzuki T, Nagai S, Yamashita T, Toyoda N, Matsushima K.
|
| Blood 96(6):2206-14. 2000
|
| 12 | CCL19
|
| Molecular cloning of a novel human CC chemokine EBI1-ligand chemokine that is a specific functional ligand for EBI1, CCR7.
|
| Yoshida R, Imai T, Hieshima K, Kusuda J, Baba M, Kitaura M, Nishimura M, Kakizaki M, Nomiyama H, Yoshie O.
|
| J Biol Chem 272(21):13803-9. 1997
|